Compare Bio Protocol (BIO) vs StakeStone (STO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs StakeStone — how do they compare? Bio Protocol trades at Rp432.99 (market cap Rp983,55M, Rp163,9M 24h volume), while StakeStone trades at Rp664.48 (market cap Rp149,54M, Rp54,61M 24h volume). The key difference: Bio Protocol is far larger — about 6.6× StakeStone's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 225,3M / 1B STO (23%) for StakeStone. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and StakeStone for 11 Days on average.
| BIO | STO | |
|---|---|---|
Market Cap | Rp983,55M | Rp149,54M |
Volume (24h) | Rp163,9M | Rp54,61M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 225,3M / 1B STO (23%) |
Typical Hold Time | 18 Days | 11 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
StakeStone (STO) is currently trading at Rp681.12 with a market cap of Rp153.39M, showing bearish technical signals overall despite neutral oscillators. The token trades near its pivot point of Rp683, with immediate support at Rp673 and resistance at Rp692. With only 23% of the maximum 1M token supply in circulation and an average hold time of 11 days, the asset shows limited distribution but relatively short-term holding patterns among current investors.
Overall outlook remains cautious with bearish momentum indicators outweighing neutral oscillators. Key opportunity lies in the token's proximity to support levels for potential rebounds, while major risks include low market cap vulnerability, limited liquidity, and the absence of recent ecosystem developments. Investors should monitor trading volume patterns and any protocol updates that could impact token utility.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About StakeStone
StakeStone is a decentralized liquidity infrastructure protocol aimed at optimizing yield generation and liquidity distribution across blockchain networks. Its solutions—such as LiquidityPad and yield-bearing ETH/BTC assets—provide liquidity providers with efficient earning opportunities while addressing the unique liquidity needs of various ecosystems and protocols.
Read more on STO →
